Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Xerostomia Therapeutics Market - Expected to Reach $796 Million by 2025 - Research and Markets

Research and Markets
Posted on: 03 Nov 17

The "Xerostomia, By Region, And Segment Forecasts, 2014 - 2025" report has been added to Research and Markets' offering.

The global xerostomia therapeutics market is expected to reach USD 796.1 million by 2025, according to a new report. Increase in favorable reimbursement policies for xerostomia products and growing awareness about associated diseases are the major factors contributing toward market growth.

In addition, increasing prevalence of xerostomia and associated diseases such as Sjogren's syndrome, diabetes, hypertension, and Parkinson's disease has a positive impact on the overall market. According to Colgate-Palmolive Company, 25 million people in the U.S. experience dry mouth. According to Sjogren Syndrome Foundation of America, around 4 million Americans are suffering from Sjogren's syndrome, an autoimmune disorder.

Growing initiatives for raising awareness about xerostomia and associated diseases are expected to drive growth. For instance, Sjogren Syndrome Foundation of America conducts awareness programs and supports patients suffering from the syndrome in the U.S. and Canada. In 2012, the foundation launched the 5-Year Breakthrough Goal with an aim to reduce the time required to diagnose the condition to less than 2.5 years by 2017.

Key Market Drivers:

  • Growing geriatric population base
  • Growing prevalence of diseases such as Sjogren's Syndrome, HIV, diabetes, Alzheimer's disease, and others.
  • Increasing adoption of chemotherapy and radiotherapy in cancer treatment
  • Increasing use of prescription medicines

Companies Mentioned

  • Acacia Pharma
  • Parnell Pharmaceuticals, Inc.
  • Pfizer, Inc.
  • GlaxoSmithKline plc
  • Church & Dwight Co., Inc.
  • Lupin
  • Sun Pharmaceutical Industries, Ltd.
  • Hikma Pharmaceuticals PLC
  • Pendopharm
  • OraCoat

Key Topics Covered:

Chapter 1 Research Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Xerostomia Therapeutics Market Variables, Trends& Scope

Chapter 4 Xerostomia Therapeutics Market: Type Estimates & Trend Analysis

Chapter 5 Xerostomia Therapeutics Market: Product Estimates & Trend Analysis

Chapter 6 Xerostomia Therapeutics Market: Regional Estimates & Trend Analysis, by Application

Chapter 7 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/research/plxtmd/xerostomia_by

View source version on businesswire.com: http://www.businesswire.com/news/home/20171103005301/en/

Business Wire
www.businesswire.com

Last updated on: 03/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.